Hi Rocketman2,

I tried to address some of your comments in a comment to my most recent SA article (http://seekingalpha.com/article/3780396-resverlogix-rvxminus-208-epigenetics-age-related-diseases).

As for what caused Hepalink to invest in Resverlogix, you have to read the entire SA article - the short answer, though, is: The science.

Best regards,

BKC